These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27502167)

  • 1. Desulfation of cell surface HSPG is an effective strategy for the treatment of gallbladder carcinoma.
    Yi B; Qiu Y; Ji W; Wei M; Liu C; Peng Z; Zhang Y; Quan Z; Tang Z; Su C
    Cancer Lett; 2016 Oct; 381(2):349-58. PubMed ID: 27502167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer.
    Qiu Y; Li X; Yi B; Zheng J; Peng Z; Zhang Z; Wu M; Shen F; Su C
    Oncotarget; 2015 Aug; 6(22):19148-62. PubMed ID: 25895131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling.
    Qin Y; Meng L; Fu Y; Quan Z; Ma M; Weng M; Zhang Z; Gao C; Shi X; Han K
    Oncotarget; 2017 Mar; 8(12):19980-19996. PubMed ID: 28212545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
    Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
    Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skp2-RNAi suppresses proliferation and migration of gallbladder carcinoma cells by enhancing p27 expression.
    Zhang B; Ji LH; Liu W; Zhao G; Wu ZY
    World J Gastroenterol; 2013 Aug; 19(30):4917-24. PubMed ID: 23946596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
    Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
    Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human sulfatase 1 exerts anti-tumor activity by inhibiting the AKT/ CDK4 signaling pathway in melanoma.
    Lou X; Sun B; Song J; Wang Y; Jiang J; Xu Y; Ren Z; Su C
    Oncotarget; 2016 Dec; 7(51):84486-84495. PubMed ID: 27806323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSulf-1 inhibits cell proliferation and invasion in human gastric cancer.
    Li J; Mo ML; Chen Z; Yang J; Li QS; Wang DJ; Zhang H; Ye YJ; Li HL; Zhang F; Zhou HM
    Cancer Sci; 2011 Oct; 102(10):1815-21. PubMed ID: 21722266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
    Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
    Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
    Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer.
    Liu B; Shen ED; Liao MM; Hu YB; Wu K; Yang P; Zhou L; Chen WD
    Tumour Biol; 2016 Jul; 37(7):9875-86. PubMed ID: 26812694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
    Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X
    Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
    Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
    Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
    Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
    Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer.
    He J; Shen S; Lu W; Zhou Y; Hou Y; Zhang Y; Jiang Y; Liu H; Shao Y
    Oncotarget; 2016 May; 7(22):32754-64. PubMed ID: 27092878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
    Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z
    Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR.
    Zhao S; Cao Y; Liu SB; Wang XA; Bao RF; Shu YJ; Hu YP; Zhang YJ; Jiang L; Zhang F; Liang HB; Li HF; Ma Q; Xu Y; Wang Z; Zhang YC; Chen L; Zhou J; Liu YB
    J Exp Clin Cancer Res; 2016 Jun; 35(1):97. PubMed ID: 27317099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.
    Kawamoto M; Onishi H; Ozono K; Yamasaki A; Imaizumi A; Kamakura S; Nakano K; Oda Y; Sumimoto H; Nakamura M
    Oncotarget; 2017 May; 8(22):36211-36224. PubMed ID: 28423707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy.
    Hu MT; Wang JH; Yu Y; Liu C; Li B; Cheng QB; Jiang XQ
    Int J Oncol; 2018 Sep; 53(3):1215-1226. PubMed ID: 30015925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.